iofemoral venous outflow obstruction. Several reports document the efficacy of
pharmacomechanical or catheter-directed pharmacologic
thrombolysis in limiting or reversing ischemic changes due
to PCD.57,62,63 Despite concerns regarding the quality of
the data, the potential benefits appear to outweigh the risks
in this life- and limb-threatening condition. The relative
infrequency of PCD with impending tissue loss, the heterogeneity of patients